Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zytomed Systems is a Germany-based pathology diagnostics company focused on cancer-related laboratory testing products rather than therapeutics. The company develops, manufactures, and sells diagnostic reagents and system solutions for immunohistochemistry, in situ hybridization, and molecular pathology, including antibodies, probes, detection systems, control materials, and automation instruments. Its products are used by clinical pathology laboratories, research institutions, and related diagnostic customers, with a broad distribution footprint outside Germany as well as direct sales in core European markets. Zytomed Systems operates as part of the broader ZYTOMICS group, which was formed by combining Zytomed Systems with ZytoVision and Diagomics. The business appears to be a commercial-stage in vitro diagnostics and pathology tools supplier rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zytomed Systems.